Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients

The Journal of Clinical Endocrinology and Metabolism
M B MarttunenO Ylikorkala

Abstract

Antiestrogens are used in the treatment, and sometimes even in the prophylaxis, of breast cancer. Tamoxifen is the most commonly used antiestrogen, but toremifene is gaining in popularity. We compared here the effects of tamoxifen and toremifene on bone metabolism and density in 30 postmenopausal patients with breast cancer, who were randomized to receive tamoxifen (20 mg/day, n = 16) or toremifene (40 mg/day, n = 14) for 1 yr. Biochemical markers of bone resorption [urinary hydroxyproline, serum cross-linked carboxyterminal telopeptide of type I collagen, urinary cross-linked aminoterminal telopeptide of type I collagen (NTx)] and bone formation [serum bone-specific alkaline phosphatase, osteocalcin, and aminoterminal and carboxyterminal propeptide of type I procollagen] were assessed before treatment and at 6 and 12 months of the antiestrogen regimen. Bone mineral density (BMD) in the lumbar spine and proximal femur (neck, trochanter, and Ward's triangle) was measured using dual-energy x-ray absorptiometry before treatment and at 12 months of treatment. Urinary NTx decreased after 6 months' use of tamoxifen (mean fall: 33%) and of toremifene (mean fall: 16%). Use of tamoxifen was associated with a significant decrease in oste...Continue Reading

Citations

Dec 26, 2012·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Feng ChiZhaoguo Xu
May 17, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·M B MarttunenO Ylikorkala
Feb 24, 2012·Expert Opinion on Drug Metabolism & Toxicology·Luigi GennariRanuccio Nuti
Apr 24, 2009·Climacteric : the Journal of the International Menopause Society·A Nath, R Sitruk-Ware
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leena VehmanenTiina Saarto
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiina SaartoInkeri Elomaa
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard EastellGlen Clack
Aug 17, 2006·The Annals of Pharmacotherapy·Aman U Buzdar, John F R Robertson
Sep 23, 2003·Menopause : the Journal of the North American Menopause Society·Eeva-Marja RutanenOlavi Ylikorkala
Dec 25, 2003·Breast Cancer Research and Treatment·J EllménD F Hayes
Aug 13, 2014·World Journal of Clinical Oncology·Mika Vj MustonenPirkko-Liisa Kellokumpu-Lehtinen
Apr 2, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Ming Zhao ChengLance E Lanyon
Jul 28, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellUNKNOWN ATAC Trialists' group
Feb 18, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Laura Boehnke Michaud, Susan Goodin
Jun 25, 2005·Current Opinion in Obstetrics & Gynecology·Anthony Howell
Dec 7, 2000·Clinical Pharmacokinetics·T L TarasM W DeGregorio
Aug 5, 2016·Molecular Endocrinology·Marjolein DroogWilbert Zwart
Jul 20, 1999·Current Opinion in Rheumatology·J C SouberbielleC Kindermans
Jul 20, 1999·Current Opinion in Rheumatology·G WeryhaJ Leclère
Oct 26, 1999·Journal of Endocrinological Investigation·J H Tobias
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R T ChlebowskiD G Pfister
Jul 17, 2004·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·J KomiO Ylikorkala
Dec 3, 2008·Expert Review of Anticancer Therapy·Sarah J Needleman, Jeffrey S Tobias
Jan 25, 2002·Annals of the New York Academy of Sciences·A C Wolff, N E Davidson
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Pfeilschifter, I J Diel
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K OsborneS A Fuqua
Mar 1, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Adi CohenShonni J Silverberg
Apr 5, 2002·Journal of the American Academy of Nurse Practitioners·J J TwissT E Moore
Oct 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R EastellR E Coleman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.